These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 8386956)
21. Malevolent lurkers no more: NMDA receptors come of age. McBain CJ; Traynelis SF J Physiol; 2006 Sep; 575(Pt 2):317-8. PubMed ID: 16809360 [No Abstract] [Full Text] [Related]
22. [Pathophysiological study of focal cortical dysplasia]. Hodozuka A; Tanaka T No Shinkei Geka; 2008 May; 36(5):385-91. PubMed ID: 18516856 [No Abstract] [Full Text] [Related]
23. The role of N-methyl-D-aspartate (NMDA) receptors in pain and morphine tolerance. Inturrisi CE Minerva Anestesiol; 2005; 71(7-8):401-3. PubMed ID: 16012411 [TBL] [Abstract][Full Text] [Related]
24. [Advances in physiopathology and the treatment of neuropathic pain]. Caviedes BE; Herranz JL Rev Neurol; 2002 Dec 1-15; 35(11):1037-48. PubMed ID: 12497311 [TBL] [Abstract][Full Text] [Related]
25. For neuropathic pain, optimize opioids. J Support Oncol; 2006 Feb; 4(2):95-6. PubMed ID: 16499135 [No Abstract] [Full Text] [Related]
27. Involvement of NMDA receptors in thiopental-induced loss of righting reflex, antinociception and anticonvulsion effects in mice. Ge ZJ; Zhang LC; Zeng YM; Da TJ; Wang JK; Cui GX; Tan YF; Zhao YP; Liu GJ Pharmacology; 2007; 80(2-3):127-33. PubMed ID: 17534122 [TBL] [Abstract][Full Text] [Related]
29. The role of nitric oxide in neuropathic pain and neurodegeneration. Gordh T Acta Anaesthesiol Scand Suppl; 1998; 113():29-30. PubMed ID: 9932117 [TBL] [Abstract][Full Text] [Related]
30. Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways. Chizh BA J Psychopharmacol; 2007 May; 21(3):259-71. PubMed ID: 17591654 [TBL] [Abstract][Full Text] [Related]
31. Excitatory amino acid-induced seizure activity and seizure-related brain damage--a possible therapeutic potential of glutamate antagonists. Czuczwar SJ; Turski WA; Kleinrok Z Pol J Pharmacol; 1998; 50(1):85-7. PubMed ID: 9662745 [No Abstract] [Full Text] [Related]
36. [The phenomena of kindling and anti-kindling under clinical conditions]. Sramka M; Fritz G; Nádvorník P; Sedlák P Cesk Neurol Neurochir; 1978 Sep; 41(5):307-12. PubMed ID: 308868 [No Abstract] [Full Text] [Related]
37. The natural history of chronic disorders of consciousness. Bernat JL Neurology; 2010 Jul; 75(3):206-7. PubMed ID: 20554939 [No Abstract] [Full Text] [Related]
38. [Clinical pharmacology of the GABAergic system (II)]. Marco Igual M Med Clin (Barc); 1994 Jun; 103(1):22-9. PubMed ID: 8051963 [No Abstract] [Full Text] [Related]
39. Current world literature. Curr Opin Neurol; 2007 Dec; 20(6):738-55. PubMed ID: 17992099 [No Abstract] [Full Text] [Related]
40. Comment on: Svendsen et al; some problems with wind-up and its calculation, PAIN 83 (1999) 109-111. Dickenson AH; Stanfa LC; Kontinen V; Suzuki R; Carpenter K Pain; 2000 Apr; 85(3):524. PubMed ID: 10866566 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]